Table 2. Key informants for the development (step 1) and assessment of the decision-analysis tool (step 3).
| Development (step 1) | Assessment (step 3) | ||||
|---|---|---|---|---|---|
| Vietnam (Aug. 2018 & March 2019) | Burkina Faso (Feb. 2020) | Thaïland (May 2020) | Argentina (July 2020) | Total | |
| Pregnant women | - | 22 | 27 | - | 49 |
| Post-partum women | 28 | 16 | 25 | - | 69 |
| Relatives/companions | - | 14 | 16 | - | 30 |
| Hospital director and department heads | 9 | 8 | 8 | - | 25 |
| Gynaecologists-obstetricians | 5 + 20* | 10 | 18 | 18* | 71 |
| Midwifes | 2 + 30* | 9 | - | 15* | 56 |
| Nurses | - | 6 | 33 | - | 39 |
| Total | 94 | 85 | 127 | 33 | 339 |
Participating hospitals: Vietnam (n = 4); Burkin Faso (n = 8); Thaïland (n = 8); Argentina (n = 8)
* Number of participants in focus group discussions (FGDs): 3 FGDs with gynaecologists-obstetricians and 4 FGDs with midwives in Vietnam; 1 FGD with gynaecologist-obstetrician and 1 FGD with midwives in Argentina.